Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,615.00
-125.00 (-4.56%)
At close: Jun 8, 2026
Psomagen Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | - | 59,192 | 43,664 | 32,275 | 43,374 |
Other Revenue | 0 | 0 | - | - | - |
| 60,702 | 59,192 | 43,664 | 32,275 | 43,374 | |
Revenue Growth (YoY) | 33.49% | 35.56% | 35.29% | -25.59% | - |
Cost of Revenue | 45,181 | 44,704 | 34,094 | 24,811 | 31,301 |
Gross Profit | 15,521 | 14,488 | 9,570 | 7,464 | 12,074 |
Selling, General & Admin | 14,113 | 14,195 | 12,326 | 8,845 | 10,105 |
Research & Development | 1,059 | 1,059 | 1,091 | 1,353 | 1,943 |
Amortization of Goodwill & Intangibles | 226.92 | 226.92 | 163.63 | 110.32 | 103.93 |
Other Operating Expenses | 559.96 | 559.96 | 607.97 | 436.41 | 467.49 |
Operating Expenses | 16,661 | 16,743 | 14,800 | 11,016 | 13,548 |
Operating Income | -1,140 | -2,255 | -5,230 | -3,553 | -1,475 |
Interest Expense | -978.31 | -978.31 | -504.07 | -219.19 | -242.02 |
Interest & Investment Income | 316.65 | 316.65 | 397.05 | 387.53 | 97.39 |
Earnings From Equity Investments | -221.47 | -346.37 | -195.2 | 14.18 | 247.24 |
Currency Exchange Gain (Loss) | 2.7 | 2.7 | -6.07 | -8.42 | 1.58 |
Other Non Operating Income (Expenses) | 45.55 | 1.09 | 71.16 | -43.28 | 0.64 |
EBT Excluding Unusual Items | -1,975 | -3,259 | -5,467 | -3,422 | -1,370 |
Gain (Loss) on Sale of Investments | - | - | - | - | 732.21 |
Gain (Loss) on Sale of Assets | 19.52 | 19.52 | 252.29 | -188.94 | 98.2 |
Asset Writedown | -887.02 | -887.02 | -1,008 | -772.92 | -502.89 |
Pretax Income | -2,843 | -4,127 | -6,223 | -4,384 | -1,042 |
Income Tax Expense | 7.65 | 7.58 | 8.71 | 10.06 | 5.96 |
Earnings From Continuing Operations | -2,850 | -4,134 | -6,232 | -4,394 | -1,048 |
Minority Interest in Earnings | 1,262 | 1,151 | 613.95 | 105.38 | - |
Net Income | -1,588 | -2,983 | -5,618 | -4,288 | -1,048 |
Net Income to Common | -1,588 | -2,983 | -5,618 | -4,288 | -1,048 |
Shares Outstanding (Basic) | 20 | 19 | 20 | 19 | 19 |
Shares Outstanding (Diluted) | 20 | 19 | 20 | 19 | 19 |
Shares Change (YoY) | 0.24% | -2.66% | 2.22% | 0.31% | - |
EPS (Basic) | -79.24 | -156.00 | -286.00 | -223.15 | -54.72 |
EPS (Diluted) | -79.24 | -156.00 | -286.00 | -223.15 | -54.72 |
Free Cash Flow | -618.79 | 625.67 | -1,001 | -3,215 | -3,024 |
Free Cash Flow Per Share | -30.88 | 32.72 | -50.98 | -167.28 | -157.84 |
Gross Margin | 25.57% | 24.48% | 21.92% | 23.13% | 27.84% |
Operating Margin | -1.88% | -3.81% | -11.98% | -11.01% | -3.40% |
Profit Margin | -2.62% | -5.04% | -12.87% | -13.29% | -2.42% |
Free Cash Flow Margin | -1.02% | 1.06% | -2.29% | -9.96% | -6.97% |
EBITDA | 3,942 | 2,932 | -96.26 | 421.96 | 2,372 |
EBITDA Margin | 6.49% | 4.95% | -0.22% | 1.31% | 5.47% |
D&A For EBITDA | 5,082 | 5,187 | 5,134 | 3,975 | 3,847 |
EBIT | -1,140 | -2,255 | -5,230 | -3,553 | -1,475 |
EBIT Margin | -1.88% | -3.81% | -11.98% | -11.01% | -3.40% |
Advertising Expenses | - | 2,330 | 1,250 | 273.88 | 942.34 |